| 注册
首页|期刊导航|中国临床药理学杂志|微小RNA-130a和微小RNA-130b在肝硬化患者血清中的表达及其意义

微小RNA-130a和微小RNA-130b在肝硬化患者血清中的表达及其意义

霍续磊 提谦 李三强 乔新杰 王善龙 张勇勇 宋颖 蔡芳宇 孙海宽 张溢煚

中国临床药理学杂志2018,Vol.34Issue(1):3-5,3.
中国临床药理学杂志2018,Vol.34Issue(1):3-5,3.DOI:10.13699/j.cnki.1001-6821.2018.01.001

微小RNA-130a和微小RNA-130b在肝硬化患者血清中的表达及其意义

Expression and significance of microRNA-130a and microRNA-130b in serum of patients with liver cirrhosis

霍续磊 1提谦 1李三强 1乔新杰 1王善龙 1张勇勇 1宋颖 1蔡芳宇 1孙海宽 1张溢煚1

作者信息

  • 1. 河南科技大学医学院肝损伤与修复分子医学重点实验室,河南洛阳4710030
  • 折叠

摘要

Abstract

Objective To study the expression and significance of microRNA-130a(miR-130a) and miR-130b in cirrhosis' serum.Methods The elbow vein blood of 15 cases of healthy subjects and 15 cases of patients with cirrhosis were collected and were divided into treatment group and control group respectively.Reverse transcription-polymerase chain reaction was used to detect the expression of miR-130a and miR-130b in serum.Results The relative expression of miR-130a in treatment group and control goup were (1.57 ±0.36)and (1.40 ± 0.46) and the relative expression of miR-130b in serum in treatment group and control group were (2.18 ± 0.60) and (1.64 ±0.26).The differences were statistically significant(P <0.05 or P <0.01).Conclusion The expression level of miR-130a and miR-130b in cirrhosis' serum is significantly higher than those in healthy person.It is likely to be used as a diagnostic marker for cirrhosis.

关键词

微小RNA-130a/微小RNA-130b/肝硬化

Key words

microRNA-130a/microRNA-130b/liver cirrhosis

分类

医药卫生

引用本文复制引用

霍续磊,提谦,李三强,乔新杰,王善龙,张勇勇,宋颖,蔡芳宇,孙海宽,张溢煚..微小RNA-130a和微小RNA-130b在肝硬化患者血清中的表达及其意义[J].中国临床药理学杂志,2018,34(1):3-5,3.

基金项目

国家自然科学基金资助项目(81201558) (81201558)

河南省科技攻关基金资助项目(172102310693) (172102310693)

河南科技大学创新团队基金资助项目(2015XTD003) (2015XTD003)

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文